1-3 of 3
Elizabeth Bengtson, MD
Close
Sort by
Journal Articles

A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, MD MMSc, Robert A. Redd, MS, Jeffrey A. Barnes, MD PhD, Elizabeth Bengtson, MD, Ronald W. Takvorian, MD, Lubomir Sokol, MD PhD, Frederick Lansigan, MD, Philippe Armand, MD PhD, Bijal D. Shah, MD, Eric D Jacobsen, MD, Donna S Neuberg, ScD, Ann S. LaCasce, MD MSc, Celeste M. Bello, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1654.
https://doi.org/10.1182/blood-2018-99-115173
Published: 2018
Journal Articles

Rapid Removal of Myeloma Light Chains By Continuous Veno-Venous Hemofiltration in a Patient with Acute Cast Nephropathy As a Result of Lambda Light Chain Myeloma

Brett L. Gourley, MD, Elizabeth Bengtson, MD, Mark Cervinski, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5426.
https://doi.org/10.1182/blood.V130.Suppl_1.5426.5426
Published: 2017
Journal Articles

Immunotherapy Immediately Following Transplantation for Multiple Myeloma: Early Recovery of Aggressive Cytotoxic Cells and Improved Immune Recovery.

Elizabeth Bengtson, MD, Jia-Yan Wu, PhD, Thomas Fitzmaurice, PhD, Cornelius J. Cornell, MD, Pamela Ely, MD, Marc Gautier, MD, John Hill, MD, Christopher H. Lowrey, MD, Kenneth Meehan, MD
Journal: Blood
Blood (2004) 104 (11): 5228.
https://doi.org/10.1182/blood.V104.11.5228.5228
Published: 2004